Your browser doesn't support javascript.
loading
Downregulation of MAL2 inhibits breast cancer progression through regulating ß-catenin/c-Myc axis.
An, Lijun; Gong, Huiyuan; Yu, Xiaojing; Zhang, Wangming; Liu, Xiaohua; Yang, Xiaomin; Shu, Liping; Liu, Jielin; Yang, Liuqi.
Afiliação
  • An L; Department of Immunology, Basic Medical College, Guizhou Medical University, Dongqing Road, Guian New District, Guiyang, Guizhou, 550004, China.
  • Gong H; Department of Immunology, Basic Medical College, Guizhou Medical University, Dongqing Road, Guian New District, Guiyang, Guizhou, 550004, China.
  • Yu X; Department of Immunology, Basic Medical College, Guizhou Medical University, Dongqing Road, Guian New District, Guiyang, Guizhou, 550004, China.
  • Zhang W; Department of Immunology, Basic Medical College, Guizhou Medical University, Dongqing Road, Guian New District, Guiyang, Guizhou, 550004, China.
  • Liu X; Department of Immunology, Basic Medical College, Guizhou Medical University, Dongqing Road, Guian New District, Guiyang, Guizhou, 550004, China.
  • Yang X; Department of Immunology, Basic Medical College, Guizhou Medical University, Dongqing Road, Guian New District, Guiyang, Guizhou, 550004, China.
  • Shu L; Department of Immunology, Basic Medical College, Guizhou Medical University, Dongqing Road, Guian New District, Guiyang, Guizhou, 550004, China.
  • Liu J; Department of Immunology, Basic Medical College, Guizhou Medical University, Dongqing Road, Guian New District, Guiyang, Guizhou, 550004, China.
  • Yang L; Department of Immunology, Basic Medical College, Guizhou Medical University, Dongqing Road, Guian New District, Guiyang, Guizhou, 550004, China. yangliuqi@163.com.
Cancer Cell Int ; 23(1): 144, 2023 Jul 21.
Article em En | MEDLINE | ID: mdl-37480012

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cancer Cell Int Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cancer Cell Int Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido